Using the upper forecast of a 35% increase in revenue on FY17 and 23% EBITDA margin, that works out to roughly ~$75m EBITDA or ~$52m NPAT. So currently trading at around PE 24. Can't see much downside at current price.
BAL price target $12, page-481
-
- There are more pages in this discussion • 46 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)